Epinephrine inhalation - Alkermes

Drug Profile

Epinephrine inhalation - Alkermes

Alternative Names: AIR Epinephrine

Latest Information Update: 27 Apr 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Alkermes
  • Class Antiarrhythmics; Antihaemorrhagics; Antihypotensives; Bronchodilators; Catecholamines; Ethanolamines; Small molecules
  • Mechanism of Action Adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anaphylaxis

Most Recent Events

  • 31 May 2006 This compound is still in active development
  • 16 Mar 2004 Data presented at the 60th American Academy of Allergy, Asthma and Immunology (AAAAI-2004) conference have been added to the pharmacokinetics and pharmacodynamics section
  • 31 Aug 2003 Phase-I clinical trials in Anaphylaxis in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top